| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 1945-RL-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35018-1mg | |||
| Carrier-Free | NBP2-35018-100ug | |||
| Carrier-Free | NBP2-35018-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35103-10ug | |||
| Carrier-Free | NBP2-35103-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35221-1mg | |||
| Carrier-Free | NBP2-35221-100ug | |||
| Carrier-Free | NBP2-35221-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1945-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35024-10ug | |||
| Carrier-Free | NBP2-35024-1mg | |||
| Carrier-Free | NBP2-35024-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35301-10ug | |||
| Carrier-Free | NBP2-35301-1mg | |||
| Carrier-Free | NBP2-35301-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35220-10ug | |||
| Carrier-Free | NBP2-35220-1mg | |||
| Carrier-Free | NBP2-35220-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43239-0.05mg | |||
![SDS-Page: Human IL-13 Protein [NBP2-35018]](http://images.novusbio.com/fullsize/Human-IL-13-Protein-SDS-Page-NBP2-35018-img0001.jpg "SDS-Page: Human IL-13 Protein [NBP2-35018]")
![SDS-Page: Mouse IL-13 Protein [NBP2-35103]](http://images.novusbio.com/fullsize/Mouse-IL-13-Protein-SDS-Page-NBP2-35103-img0001.jpg "SDS-Page: Mouse IL-13 Protein [NBP2-35103]")
![SDS-Page: Rat IL-13 113 a.a Protein [NBP2-35221]](http://images.novusbio.com/fullsize/Rat-IL-13-113-a.a-Protein-SDS-Page-NBP2-35221-img0001.jpg "SDS-Page: Rat IL-13 113 a.a Protein [NBP2-35221]")
![SDS-Page: Recombinant Human IL-13 Variant Protein [NBP2-35024]](http://images.novusbio.com/fullsize/Recombinant-Human-IL-13-Variant-Protein-SDS-Page-NBP2-35024-img0002.jpg "SDS-Page: Recombinant Human IL-13 Variant Protein [NBP2-35024]")
![SDS-Page: Primate IL-13 Protein [NBP2-35301]](http://images.novusbio.com/fullsize/Primate-IL-13-Protein-SDS-Page-NBP2-35301-img0001.jpg "SDS-Page: Primate IL-13 Protein [NBP2-35301]")
![SDS-Page: Recombinant Rat IL-13 Protein [NBP2-35220]](http://images.novusbio.com/fullsize/Recombinant-Rat-IL-13-Protein-SDS-Page-NBP2-35220-img0002.jpg "SDS-Page: Recombinant Rat IL-13 Protein [NBP2-35220]")
![Immunohistochemistry-Paraffin: IL-13 Antibody (2B5) [H00003596-M07] - Analysis of monoclonal antibody to IL13 on formalin-fixed paraffin-embedded human testis. Antibody concentration 3 ug/ml](http://images.novusbio.com/fullsize/IL-13-Antibody-2B5-Immunohistochemistry-Paraffin-H00003596-M07-img0001.jpg "Immunohistochemistry-Paraffin: IL-13 Antibody (2B5) [H00003596-M07] - Analysis of monoclonal antibody to IL13 on formalin-fixed paraffin-embedded human testis. Antibody concentration 3 ug/ml")
![Western Blot: IL-13 Antibody [NBP1-42776] - Analysis of recombinant swine IL-13 at 13.2kDa (arrow) raised in yeast. Multiple bands are expected of the glycosylated protein. Protein was purified and resolved by SDS-PAGE, then transferred to PVDF membrane. Membrane was blocked with 3% BSA (BSA-30, diluted 1:10), and probed with , Inc. Anti-swine IL-13. After washing, membrane was probed with Dylight 649 Conjugated Anti-Rabbit IgG (H&L) (Donkey) Antibody.](http://images.novusbio.com/fullsize/IL-13-Antibody-Western-Blot-NBP1-42776-img0004.jpg "Western Blot: IL-13 Antibody [NBP1-42776] - Analysis of recombinant swine IL-13 at 13.2kDa (arrow) raised in yeast. Multiple bands are expected of the glycosylated protein. Protein was purified and resolved by SDS-PAGE, then transferred to PVDF membrane. Membrane was blocked with 3% BSA (BSA-30, diluted 1:10), and probed with , Inc. Anti-swine IL-13. After washing, membrane was probed with Dylight 649 Conjugated Anti-Rabbit IgG (H&L) (Donkey) Antibody.")
![Flow Cytometry: IL-13 Antibody (13A) [NBP1-43239] - Analysis using PE conjugate of NBP1-43239. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (cat. 16-0031), soluble Anti-Mouse CD28 Functional Grade Purified (cat. 16-0281), Mouse IL-2 Recombinant Protein (cat. 14-8021), and Mouse IL-4 Recombinant Protein (cat. 14-8041). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized then stained with Anti-Mouse CD4 FITC (cat. 11-0042) and 0.125 ug of Rat IgG1 K Isotype Control PE (cat. 12-4301) or 0.125 ug of Anti-Mouse IL-13 PE. Viable cells, as determined by Fixable Viability Dye eFluor® 780, were used for analysis.](http://images.novusbio.com/fullsize/IL-13-Antibody-13A-Flow-Cytometry-NBP1-43239-img0001.jpg "Flow Cytometry: IL-13 Antibody (13A) [NBP1-43239] - Analysis using PE conjugate of NBP1-43239. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (cat. 16-0031), soluble Anti-Mouse CD28 Functional Grade Purified (cat. 16-0281), Mouse IL-2 Recombinant Protein (cat. 14-8021), and Mouse IL-4 Recombinant Protein (cat. 14-8041). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized then stained with Anti-Mouse CD4 FITC (cat. 11-0042) and 0.125 ug of Rat IgG1 K Isotype Control PE (cat. 12-4301) or 0.125 ug of Anti-Mouse IL-13 PE. Viable cells, as determined by Fixable Viability Dye eFluor® 780, were used for analysis.")